CSPG4 and melanoma: In concordance with IHC evaluations using a commercial mouse antibody clone, CSPG4 IgE showed positive staining of ~70–75% of all malignant melanomas (n = 468), and when divided into cutaneous lesions, lymph node and distant metastases (n = 302).